tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Kerry Holford, 13 are a HOLD (59.09%), 9 are a BUY (40.91%).
Analyst Kerry Holford, currently employed at BERENBERG, carries an average stock price target met ratio of 75% that have a potential upside of 15.63% achieved within 156 days.
Kerry Holford’s has documented 38 price targets and ratings displayed on 4 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on LLY, Eli Lilly and Company at 16-Sep-2025.
Analyst best performing recommendations are on NVO (NOVO NORDISK A/S).
The best stock recommendation documented was for NVO (NOVO NORDISK A/S) at 12/5/2023. The price target of $94.36 was fulfilled within 1 day with a profit of $1.54 (1.61%) receiving and performance score of 16.06.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$41
$-2.54 (-5.83%)
10 months 14 days ago
(01-Dec-2024)
1/1 (100%)
$7.82 (23.57%)
182
Hold
$53
11 months 4 days ago
(11-Nov-2024)
3/5 (60%)
$16.8 (46.41%)
323
Buy
1 years 2 months 15 days ago
(31-Jul-2024)
0/13 (0%)
$-16.49 (-43.22%)
Buy
$45
$1.46 (3.35%)
$47
1 years 3 months ago
(15-Jul-2024)
2/3 (66.67%)
$8.15 (22.12%)
976
Buy
$19.52
1 years 8 months 3 days ago
(12-Feb-2024)
0/3 (0%)
$-12.79 (-39.59%)
Which stock is Kerry Holford is most bullish on?
Which stock is Kerry Holford is most reserved on?
What Year was the first public recommendation made by Kerry Holford?
